Also found in: Wikipedia.
nimodipine/ni·mo·di·pine/ (ni-mo´dĭ-pēn) a calcium channel blocker used as a vasodilator in the treatment of neurologic deficits associated with subarachnoid hemorrhage from a ruptured intracranial aneurysm.
A calcium channel blocker used to reduce neurological damage after subarachnoid hemorrhage.
a calcium channel blocking agent used as a vasodilator in the treatment of neurological deficits associated with subarachnoid hemorrhage from a ruptured intracranial aneurysm, administered orally.
nimodipineAn dihydropyridine L-type calcium channel antagonist originally developed for treating hypertension; it is now used to prevent vasospasm in subarachnoid haemorrhage. Nimodipine preferentially binds to the channels when cells are depolarised, maintaining them in an opened state and theoretically preventing the accumulation of glutamate, which has been pathogenically linked to AIDS dementia complex.
nimodipineA CALCIUM CHANNEL BLOCKER drug used to minimise brain damage after subarachnoid haemorrhage. A brand name is Nimotop.
A calcium-channel blocker, that is, a drug that relaxes arterial smooth muscle by slowing the movement of calcium across cell walls.
Mentioned in: Cerebral Aneurysm